None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female subjects. 2. Age above 18 years. 3. Willingness to participate after providing informed consent.
Exclusion criteria
Exclusion criteria: 1. Female patients who are pregnant or lactating. 2. Patients with pacemaker implantation 3. Patients suffering from cardio-respiratory, neurological or endocrinal disorders or any other condition whatsoever, which in judgement of the Investigator deemed unfit for the study inclusion as evident from the medical history/concurrent illness(s). 4. Patients based on abnormal rhythms as evident by the current ECG and medical history/concurrent illness(s). 5. Medical or surgical indication that might prevent use of ECG. 6. Patients who have completed participation in any other clinical trial during the past six (06) months. 7. Patients on mechanical ventilation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To validate the accuracy of Cicer, a non-invasive electrocardiography device, in comparison to reference 12-Lead ECG (FDA/CE marked device) in healthy and individuals with a medical condition, as per the standards of ANSI/AAMI/ISO 14155:2011.Timepoint: One day | — |
Secondary
| Measure | Time frame |
|---|---|
| Validation of Cicer non-invasive electrocardiography deviceTimepoint: one day | — |
Countries
India
Contacts
Ten3T Healthcare Pvt Ltd